Zota Health Care's Q2 FY 2025-26 Quarterly Results

Result Summary

• Zota Health Care Ltd reported a 25.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 92.5%.
• Its expenses for the quarter were up by 23.3% QoQ and 80.1% YoY.
• The net profit increased 17.5% QoQ and increased 32.9% YoY.
• The earnings per share (EPS) of Zota Health Care Ltd declined at 5.02 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Zota Health Care Ltd is a company primarily involved in the pharmaceutical industry, focusing on the manufacturing and distribution of healthcare products. The company develops a range of pharmaceutical formulations, herbal products, and nutraceuticals. Zota Health Care Ltd operates within the broader healthcare sector, targeting domestic and international markets. As of the information available up to October 2023, specific recent major developments about the company are not provided in the dataset, so further details about recent strategic changes or expansions are not included in this analysis.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Zota Health Care Ltd reported a total income of ₹130.58 crores. This represents a quarter-over-quarter (QoQ) increase of 25.0% from ₹104.46 crores in Q1FY26. Compared to the second quarter of the previous fiscal year (Q2FY25), total income increased by 92.5%, up from ₹67.82 crores. The significant year-over-year (YoY) growth highlights a substantial increase in revenue generation, suggesting an expansion in the company's operations or market presence over the past year. These figures indicate a robust performance in terms of revenue for the company during the reported period.

Profitability

Zota Health Care Ltd's profitability metrics for Q2FY26 reveal a profit before tax of -₹14.38 crores, reflecting a deterioration compared to the -₹13.08 crores reported in Q1FY26, marking a 9.9% QoQ decrease. On a YoY basis, the profit before tax has also decreased by 13.3% from -₹12.69 crores in Q2FY25. The company incurred a tax expense of ₹1.81 crores in Q2FY26, which is a significant increase of 162.3% QoQ from ₹0.69 crores in Q1FY26. In the previous year, Q2FY25, the tax was -₹0.51 crores, leading to a YoY change of -454.9%. Profit after tax for Q2FY26 stood at -₹16.19 crores, a 17.5% QoQ decline from -₹13.78 crores in Q1FY26 and a 32.9% YoY decline from -₹12.18 crores in Q2FY25. Earnings per share for Q2FY26 were -₹5.02, compared to -₹4.56 in Q1FY26 and -₹4.23 in Q2FY25, indicating a QoQ change of 10.1% and a YoY change of 18.7%.

Operating Metrics

The financial data for Zota Health Care Ltd in Q2FY26 shows a total expense of ₹144.97 crores, which increased by 23.3% QoQ from ₹117.55 crores in Q1FY26. This represents an 80.1% increase YoY from ₹80.51 crores in Q2FY25. The company's operating metrics reflect an increase in expenses, which could be attributed to factors such as increased production costs, marketing expenses, or expansion activities. The consistent rise in both quarterly and yearly expenses is a critical aspect of the company's financial performance that warrants attention. The analysis of these metrics provides insight into the cost dynamics and operational scale adjustments that might have occurred during the reported period.